 
                        
                                          Research
OCRA invests more funds into ovarian cancer research than any other public charity.
Read more about Research Read about groundbreaking OCRA-funded research
Our Mission Statement: Ovarian Cancer Research Alliance is dedicated to curing ovarian cancer while improving treatments by advancing innovative science, promoting preventive measures, and advocating for, educating and supporting anyone affected by gynecologic cancers to ensure the best possible care and outcomes.
 
        
      Numbers tell the story of our impact
For each dollar we spend, 81 cents goes to funding critical research and innovative programs
OCRA has both a laser focus and a panoramic view when it comes to the fight against gynecologic cancers.
 
                        
                                          OCRA invests more funds into ovarian cancer research than any other public charity.
Read more about Research Read about groundbreaking OCRA-funded research
 
                        
                                          OCRA has built a team of passionate, dedicated advocates.
Read more about Advocacy Discover our advocacy impact and get involved
 
                        
                                          In times of adversity, support becomes a beacon of hope.
Read more about Patient Support Learn about our unique programs
 
          Ovarian Cancer Research Alliance (OCRA) is the oldest and largest ovarian and gynecologic cancer charity in the world. Since its founding in 1994, OCRA has grown into the leading non-government funder of ovarian and related gynecologic cancer research, investing over $137 million in groundbreaking studies. Through innovative education and advocacy efforts, compassionate support programs, and cross-industry collaboration, OCRA is driving progress and pushing the boundaries of what’s possible to improve outcomes for patients and advance research in its quest for a cure.
 
              
            
          KVIA-TV ABC-7 News El Paso recently featured OCRA-funded researcher Daniel Heller, PhD, and his team at Memorial Sloan Kettering Cancer Center, whose innovative work is bringing new hope for detecting ovarian cancer at its earliest stages through a simple blood test. Dr. Heller’s research lab is developing a liquid biopsy that uses nanosensors and artificial intelligence (AI) to measure multiple proteins … Continued
 
              
            
          This article was updated in October 2025 to reflect NCCN’s release of the 2025 Guidelines for Uterine Cancer Patients. OCRA is a proud sponsor of the 2025 Patient Guidelines for Cervical, Ovarian, and Uterine Cancer. We believe ensuring access to clear, understandable information is critical. NCCN provides wonderful guides for anyone newly diagnosed to help … Continued
 
              
            
          In a recent article for the Fort Worth Star-Telegram, Jeff Guttenfelder spoke with journalist Ciara McCarthy about losing his late wife, Ni, to ovarian cancer, and how he is channeling his grief into action through participation in OCRA’s Survivors Teaching Students program. Read the article “Fort Worth man’s wife died of ovarian cancer” in the … Continued
Get email updates about research news, action alerts, and ways to join the fight.